Avandia, a Case of Deja Vu all over again
“The scariest thing is that nobody knows” risks of depression drugs for children Mon, 10 May 2004 Forest Laboratories, manufacturer of the antidepressant, Celexa / Lexapro, is the latest manufacturer to issue warnings (April 2004) about the possibility that “patients with major depressive disorder, both adult and pediatric, may experience…
Spitzer’s Lawsuit Will Shake Up the Drug Industry – Full Disclosure is the Goal Thu, 3 Jun 2004 New York State Attorney General, Eliot Spitzer’s lawsuit against GlaxoSmithKline challenges the pharmaceutical industry’s fraudulent marketing of drugs. Karen Barth Menzes, an attorney representing victims of antidepressant drug effects, told The (So….
NAMI’s Pharma Funders – Serial Off-label Promoter Astrazeneca Tops the List
The National Alliance on Mental Illness (NAMI) until recently was reluctant to reveal the source of its funding. But thanks to Sen. Grassley we now can learn NAMI’s sources for Major Foundation and Corporate Support.
Minn. Shooter Described As Deeply Disturbed-He took Prozac – Wash Post Thu, 24 Mar 2005 The Chicago Tribune and The Washington Post confirm the suspicion that like the other adolescents who went on a school shooting rampage, Jeff Weise was taking an SSRI antidepressant. The Post identifies the drug as…
Our criticism of a high risk, speculative drug experiment conducted on healthy children and adolescents at Yale University’s Psychiatric Institute was validated by a federal investigation: and our criticism is now validated by the principle investigator, Dr. Thomas McGlashan.
Harvard research in China: Open Letter to Pres. Summers Sat, 12 Apr 2003 On May 15, 2002, The Boston Globe reported that Lawrence Summers, the President of Harvard University, “expressed deep regret that a dozen Harvard-run genetic studies in China failed to give test subjects adequate information about potential pitfalls.”…